MAY 11, 2021 8:00 AM PDT

Immune Cells Help Brain Tumors Spread, but We Can Stop Them

WRITTEN BY: Tara Fernandez

Researchers have discovered how a glitch in the brain’s immune system can inadvertently cause an accelerated growth and spread of brain tumors. However, therapeutically “fixing” this failure to restore the activity of the immune system can halt the progression of these deadly, aggressive cancers.

“Glioblastoma is the deadliest type of cancer in the central nervous system, accounting for most malignant brain tumors,” explained Professor Ronit Satchi-Fainaro from Tel Aviv University, lead author of the study. “It is aggressive, invasive, and fast-growing, making it resistant to existing treatments, with patients dying within a year of the cancer’s onset.”

“Moreover, glioblastoma is defined as a ‘cold tumor’, which means that it does not respond to immunotherapeutic attempts to activate the immune system against it.”

Neural tissue is guarded by a specialized immune cell unique to the brain called microglia. However, until now, neuroscientists were not clear as to why microglia fail to detect and eliminate glioblastomas. Satchi-Fainaro and colleagues took a closer look at brain tissue samples from glioblastoma patients and made a surprising discovery. 

“To our surprise, we found that not only do the microglia cells do nothing to stop the cancer cells, they actually play a crucial and negative role by accelerating the division, spread, and mobilization of glioblastoma cells,” said Satchi-Fainaro.

The team identified the mechanism behind this curious phenomenon: a protein called P-Selectin, or SELP. Under normal conditions, SELP facilitates the movement of cells, such as the passage of white blood cells as they travel within blood vessels. The researchers found that glioblastoma cells caused microglia to churn out abnormally large quantities of SELP, which gave the cancer cells the power to infiltrate brain tissue faster.

Fascinatingly, the scientists found that silencing SELP synthesis in microglia slowed down tumor growth and halted the migration of glioblastoma cells, pumping the brakes on cancer progression.

Whether or not SELP inhibitors will work in glioblastoma patients will be the subject of future clinical trials. “Our treatment may be the needed breakthrough in the battle against the most daunting cancer of all,” commented Satchi-Fainaro.

 

 

Sources: Nature Communications, Tel Aviv University.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
FEB 03, 2021
Immunology
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
FEB 03, 2021
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
Researchers are still studying how long a person can stay immune against COVID-19 following infection. A new study by a ...
MAR 22, 2021
Cell & Molecular Biology
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
MAR 22, 2021
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
Immunotherapy aims to make a patient's immune cells better at fighting cancer. The immune system has to be used carefull ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
APR 03, 2021
Cancer
New factor plays a key role in immune response
APR 03, 2021
New factor plays a key role in immune response
In a study published recently in Science Immunology, WEHI’s Professor Stephen Nutt, Dr. Michael Chopin, and Mr. Sh ...
APR 23, 2021
Microbiology
A Causal Connection Between C-Section Births & Food Allergies
APR 23, 2021
A Causal Connection Between C-Section Births & Food Allergies
The microbes that live in the human gut have a powerful influence on our health, and that microbial community is with us ...
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
Loading Comments...